TP53 and cancer: The mutational landscape of all patients revealed that TP53 is the most frequently mutated cancer gene in the whole cohort and in all the subgroups, which otherwise show diverse mutational profiles (Fig. 3a, Supplementary Fig. 1A and Supplementary Table 3).